Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. - Wikidata - wikimedia - TriplyDB

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

http://www.wikidata.org/entity/Q34269067

about

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis Highlight on advances in nontuberculous mycobacterial disease in North America.Managing pulmonary nontuberculous mycobacterial infection. time for a patient-centered approach.'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection Understanding nontuberculous mycobacterial lung disease: it's been a long time coming Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis Epidemiology and Ecology of Opportunistic Premise Plumbing Pathogens: Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights Gene replacement in Mycobacterium chelonae: application to the construction of porin knock-out mutants Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries Increased virulence of an epidemic strain of Mycobacterium massiliense in mice Spectrum and Clinical Course of Visual Field Abnormalities in Ethambutol Toxicity.Management of nontuberculous mycobacterial infection in the elderly.The epidemiology of pulmonary nontuberculous mycobacteria: data from a general hospital in Athens, Greece, 2007-2013.Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease.Development and validation of a prognostic scoring model for Mycobacterium avium complex lung disease: an observational cohort study.Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients.Genome sequencing of Mycobacterium abscessus isolates from patients in the united states and comparisons to globally diverse clinical strains.Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease.Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.Association of CFTR gene variants with nontuberculous mycobacterial lung disease in a Korean population with a low prevalence of cystic fibrosis.Monocyte-derived macrophages do not explain susceptibility to pulmonary non-tuberculous mycobacterial disease.The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011 Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis Proposed definitions for epidemiologic and clinical studies of Mycobacterium avium complex pulmonary disease.Mycobacterium abscessus morphotype comparison in a murine model.The hidden 'mycobacteriome' of the human healthy oral cavity and upper respiratory tract.Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.Epidemiology and clinical features of pulmonary nontuberculous mycobacteriosis in Nagasaki, Japan.Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study.

P2860

Q26775974-ECF86B35-636E-4991-AC49-94D8EC9D5C2B Q27028191-53D815B4-09CE-423A-ACA5-F2B11C883D1A Q27693348-8B22A49C-A593-4122-817F-33EB9E79A9EF Q28070339-A6E15D86-B631-439F-B8D9-06E8A4A58599 Q28071355-667E9204-397F-48ED-91AA-1404BDF823C1 Q28081189-F2002D5A-96BE-4BE2-91F7-1E63ADFE38DE Q28083865-C3B70613-F64B-40E9-B806-DAAA9324B4F6 Q28084520-3A9D8FAD-BF6E-4968-B3A9-8B3076A9DFF3 Q28084682-0D60F562-69F5-4F9A-9530-4F81809BBD64 Q28087593-D2F1FF06-551D-46B8-B6EF-0EB031EC7891 Q28537956-F9AF2A46-4009-4DA1-9BC1-0794D1321143 Q28552480-ABEA35C0-CD72-4888-AFF4-76BF11ABA984 Q28729217-0BA4C69E-0BC7-48E4-9492-65A2F5761C56 Q28740469-C34A7EF4-6C1A-4B09-9D27-3C7DBC147A43 Q30275276-6CD3FEB4-DC69-434F-B6E8-335FA4E65627 Q30406048-4348AC34-C591-41A3-87F5-3854F0D1AE93 Q30843389-F0256868-6501-4754-8523-47B93380D05A Q33732183-4B092863-EC1A-4B2D-8907-6211EFC87587 Q33745642-AE4DC58C-6F2B-44FC-B7BA-A7E28D88D5CE Q33814448-547CF61B-8667-4349-AA89-082F055AE7D3 Q33855122-8EB6656A-5086-4FA5-91BB-E3A8CCA5B859 Q34298088-0A696EC5-04A5-4EB0-B0BB-72A9811B56DB Q34419659-249B4939-CD1C-431B-85BD-40FACE398F23 Q34425638-8F6CAF11-752B-4ED2-8268-C8FF4A906949 Q34425805-59D708E6-D140-4337-B3E8-2986761E32BE Q34628792-50CD49C7-E303-4C2D-B638-53DC80114557 Q34635263-B106CE7B-9A2E-44E4-90C3-FA1550404F7D Q34669152-7AA75C20-993E-424A-B123-13C2C0783359 Q34732855-47C41C19-D5D9-4352-AE1E-673FD06F60E6 Q34855443-0D2FB9AD-79B7-4D3A-94BD-2E93F8158537 Q35050258-57AC0C0F-50D7-4F85-87F9-420B82DFB88E Q35078472-7489046E-03B4-41EA-A2CE-4C63060915FE Q35085968-4FD74CB8-60E5-4E1F-BB58-0B6A572568C4 Q35121799-6E2764D8-40A8-4120-9D71-0FAC06519E2D Q35140420-DACEB81D-E21C-4866-AEC9-15982151556B Q35469357-49D4F456-A9E5-4E55-BA95-37F3DF22A9DA Q35565155-530CB1B8-FC9D-47EE-B2D7-CF12FE2948CB Q35645138-E7EBF6F9-0BE6-4D09-BF4C-72C7F99F1075 Q35726884-E6E11049-68BB-41D9-A9F6-545431D8DF2B Q35826719-9440A1FB-9CA3-4903-A150-16BF018707A8

P2860

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

http://www.wikidata.org/entity/Q34269067

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nontuberculous mycobacterial l ...... health care delivery systems.

@ast

Nontuberculous mycobacterial l ...... health care delivery systems.

@en

Nontuberculous mycobacterial l ...... health care delivery systems.

@nl

type

label

Nontuberculous mycobacterial l ...... health care delivery systems.

@ast

Nontuberculous mycobacterial l ...... health care delivery systems.

@en

Nontuberculous mycobacterial l ...... health care delivery systems.

@nl

prefLabel

Nontuberculous mycobacterial l ...... health care delivery systems.

@ast

Nontuberculous mycobacterial l ...... health care delivery systems.

@en

Nontuberculous mycobacterial l ...... health care delivery systems.

@nl

P1433

Q34269067-8AE05B16-D643-4DCD-A6F1-23F7531E695E

P1476

Q34269067-4C502A9F-049A-4FAE-A18C-72D1FD69C2F1

P2093

Q34269067-1FBE5A60-B973-458F-9CAB-BAECB6F0EB37

Q34269067-2A13C7AB-CB8F-43E7-BD5F-F0507C67BD8E

Q34269067-3F0723E3-B2B4-48D5-AB2E-37EE628218A2

Q34269067-4BABC38E-276B-434C-922B-D8EA1FD806A4

Q34269067-7CEECA28-4536-4C62-8782-FAD50EBC3E4E

Q34269067-81685B95-5861-4193-A6AB-CDCC732E3D51

Q34269067-960470FA-D743-4F1A-97C6-CBF5BAB403C8

Q34269067-BA5F059B-2315-43CA-BEB6-DDBFA3588462

Q34269067-D8467765-5E66-409B-9D5E-31D72CB97AE5

Q34269067-DB1D5D20-F64D-49F7-A378-CF84922BDE1E

P2860

Q34269067-0A554BC1-7B4A-46F2-BC3C-F700FF458737

Q34269067-0B000421-490D-4B74-994D-352C349B4941

Q34269067-2D3F8670-387B-4543-A7E6-01FA55565CB6

Q34269067-2F2EC4E8-8C16-4942-96AC-8D16CA2AF4EA

Q34269067-448A4818-E328-42C3-9FD5-A5193507CC99

Q34269067-4C0B2814-040C-4E71-A792-35D98FB137F7

Q34269067-58BAFD33-CA5F-431E-A783-2765F33AA356

Q34269067-59C87623-F429-477F-8CCF-CC93AFE7E58B

Q34269067-6AC55856-2269-4569-B062-7290348613A3

Q34269067-6E625430-F9C4-46AC-8FDF-8B9E505E9260

P304

Q34269067-6BE9C92F-F8B3-427E-9B79-9DF428E85C11

P31

Q34269067-54289769-0C8C-4B13-A851-55DCAFD86093

P356

Q34269067-BB2130A6-0107-4AB9-9A87-D5C94315001F

P407

Q34269067-F18CCD03-F4D3-4FD3-9447-BC3634E7B48E

P433

Q34269067-06B85487-0084-4AF0-A001-155E64AFFA47

P478

Q34269067-0FDCA8C5-CA57-4B08-8BEF-4E38D2EC7F62

P577

Q34269067-98D2C643-B66D-49F1-A7A2-166A4EAC229A

P698

Q34269067-118B2C65-84AD-46C6-8701-275E1FD5EEB3

P932

Q34269067-24C2357B-7231-4363-A310-E07DF8D22D63

P356

RCCM.201002-0310OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Nontuberculous mycobacterial l ...... health care delivery systems.

@en

P2093

Amy E Seitz

http://www.w3.org/2001/XMLSchema#string

D Rebecca Prevots

http://www.w3.org/2001/XMLSchema#string

Daniel Strickland

http://www.w3.org/2001/XMLSchema#string

Kenneth N Olivier

http://www.w3.org/2001/XMLSchema#string

Lisa A Jackson

http://www.w3.org/2001/XMLSchema#string

Marsha A Raebel

http://www.w3.org/2001/XMLSchema#string

Mary Ann Blosky

http://www.w3.org/2001/XMLSchema#string

Pamela A Shaw

http://www.w3.org/2001/XMLSchema#string

Ruben Montes de Oca

http://www.w3.org/2001/XMLSchema#string

Steven M Holland

http://www.w3.org/2001/XMLSchema#string

P2860

Nontuberculous mycobacteria in the environment.

Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005.

Mycobacterium avium complex pulmonary disease in patients without HIV infection.

U.S. hospital mycobacteriology laboratories: status and comparison with state public health department laboratories

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.

Mycobacterium avium complex, an emerging pathogen in Massachusetts

Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome

Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs

Moraxella catarrhalis, a human respiratory tract pathogen.

P304

970-976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201002-0310OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20538958

http://www.w3.org/2001/XMLSchema#string

P932

2970866

http://www.w3.org/2001/XMLSchema#string